These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 37722463)
81. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome. Cohen H; Isenberg DA Blood; 2021 Jan; 137(3):299-309. PubMed ID: 32898856 [TBL] [Abstract][Full Text] [Related]
82. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality. Riancho-Zarrabeitia L; Martínez-Taboada V; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Fernández-Nebro A; Calvo-Alén J; Menor-Almagro R; Tomero-Muriel E; Uriarte-Isacelaya E; Botenau A; Andres M; Freire-González M; Santos Soler G; Ruiz-Lucea E; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez-García J; Expósito L; Hernández-Beriaín JA; Horcada L; Aurrecoechea E; Pego-Reigosa JM Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021 [TBL] [Abstract][Full Text] [Related]
83. Lupus-Induced Vasculitis and Multiple Organ Dysfunction Syndrome as the First Presentation of Systemic Lupus Erythematosus (SLE) in Pregnancy. Yousif PA; Moshrefi H; Meysami A; Alkhatib AH Am J Case Rep; 2020 Apr; 21():e921299. PubMed ID: 32284523 [TBL] [Abstract][Full Text] [Related]
84. Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. Sciascia S; Radin M; Cecchi I; Bertolaccini ML; Bertero MT; Rubini E; Vaccarino A; Bazzan M; Giachino O; Baldovino S; Rossi D; Mengozzi G; Roccatello D Rheumatology (Oxford); 2021 Mar; 60(3):1106-1113. PubMed ID: 31840749 [TBL] [Abstract][Full Text] [Related]
85. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies. Gabrielli F; Alcini E; Di Prima MA; Mazzacurati G; Masala C Int J Cardiol; 1995 Sep; 51(2):117-26. PubMed ID: 8522406 [TBL] [Abstract][Full Text] [Related]
86. Systemic lupus erythematosus-associated diffuse alveolar haemorrhage: a single-centre experience in Han Chinese patients. Wang CR; Liu MF; Weng CT; Lin WC; Li WT; Tsai HW Scand J Rheumatol; 2018 Sep; 47(5):392-399. PubMed ID: 29916287 [TBL] [Abstract][Full Text] [Related]
87. Pulmonary capillaritis, alveolar hemorrhage, and recurrent microvascular thrombosis in primary antiphospholipid syndrome. Gertner E; Lie JT J Rheumatol; 1993 Jul; 20(7):1224-8. PubMed ID: 8371225 [TBL] [Abstract][Full Text] [Related]
88. Risk factors and outcomes of immune and non-immune causes of diffuse alveolar hemorrhage: a tertiary-care academic single-center experience. Bhushan A; Choi D; Maresh G; Deodhar A Rheumatol Int; 2022 Mar; 42(3):485-492. PubMed ID: 33782747 [TBL] [Abstract][Full Text] [Related]
89. Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study. Laurent C; Ricard L; Nguyen Y; Boffa JJ; Rondeau E; Gerotziafas G; Elalamy I; Deriaz S; De Moreuil C; Planche V; Johanet C; Millot F; Fain O; Mekinian A RMD Open; 2023 Mar; 9(1):. PubMed ID: 37001919 [TBL] [Abstract][Full Text] [Related]
90. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Campos LM; Kiss MH; D'Amico EA; Silva CA Lupus; 2003; 12(11):820-6. PubMed ID: 14667097 [TBL] [Abstract][Full Text] [Related]
91. Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations. Rangel ML; Alghamdi I; Contreras G; Harrington T; Thomas DB; Barisoni L; Andrews D; Wolf M; Asif A; Nayer A Lupus; 2013 Jul; 22(8):855-64. PubMed ID: 23722230 [TBL] [Abstract][Full Text] [Related]
92. Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series. Madison JA; Gockman K; Hoy C; Tambralli A; Zuo Y; Knight JS Pediatr Rheumatol Online J; 2022 Feb; 20(1):17. PubMed ID: 35197077 [TBL] [Abstract][Full Text] [Related]
95. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121 [TBL] [Abstract][Full Text] [Related]
96. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS"). Asherson RA Autoimmun Rev; 2006 Dec; 6(2):76-80. PubMed ID: 17138247 [TBL] [Abstract][Full Text] [Related]
97. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. Marai I; Levi Y; Godard G; Shoenfeld Y Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848 [TBL] [Abstract][Full Text] [Related]
98. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients. Ma J; Song H; Wei M; He Y Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509 [TBL] [Abstract][Full Text] [Related]